Mahmoud Hashim

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2020
Publications (10 Years): 3

Top Topics

Cognitive Decline

Newly Diagnosed

Electronic Health Record

Top Venues

Expert review of pharmacoeconomics & outcomes research

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Anders Gustavsson, Peter Pemberton-Ross, Melissa Gomez Montero, Mahmoud Hashim, Robin Thompson
Challenges in demonstrating the value of disease-modifying therapies for Alzheimer's disease. Expert review of pharmacoeconomics & outcomes research 20 (6) (2020)
Maria-Victoria Mateos-Manteca, Jesús San F Miguel, Hartmut Goldschmidt, Pieter Sonneveld, Meletios- Athanasios Dimopoulos, Bart Heeg, Mahmoud Hashim, William Deraedt, Peter Hu, Annette Lam, Jianming He
The effects of different schedules of bortezomib, melphalan, and prednisone for patients with newly diagnosed multiple myeloma who are transplant ineligible: a matching-adjusted indirect comparison. Leukemia & lymphoma 61 (3) (2019)
Samron Brhane Gebregergish, Mahmoud Hashim, Bart Heeg, Thomas Wilke, Marco Rauland, Ulrike Hostalek
The cost-effectiveness of metformin in pre-diabetics: a systematic literature review of health economic evaluations. Expert review of pharmacoeconomics & outcomes research 20 (2) (2019)